• Vertical nystagmus (present only with very high doses)
• Lack of convergence (present) • Pulse may be slow, but unlikely to be much slower outside the range of normal (60-90 BPM)
• Romberg internal clock may be slow, possibly outside the range of normal (30 +/- 10 seconds)
• Pupil size will be in the range of normal • Pupil reaction to light may be sluggish • Speech may be slow, perhaps even slurred (at high doses only)
• Mouth and oral cavity may be dry • Balance and gait may be affected, in much the same manner as alcohol intoxication
• High doses will reveal classic signs of alcohol intoxication without the telltale odor For readers who are professionals that
help treat recovering alcoholics, this month’s drug is a top shelf therapy for the treatment of the symptoms of withdrawal. In this role, the drug is a safe and reliable therapy for what oſtentimes can be an agonizing and potentially fatal set of symptoms. In this role, the drug may be utilized for several weeks following entry into detoxification and treatment. Te drug is affordable and widely available in the United States. This month’s drug is the chemical
godfather of all benzodiazepines. It gave
rise to more famous second-generation drugs, such as Valium and Ativan. Suc- cessive derivatives took shape in the form of sleeping aids, such as Dalmane and Restoril. Later developments included the blockbuster anxiolytic Xanax and the anticonvulsant Klonopin. Indeed this month’s mystery drug was a trailblazer, a progenitor for a class of medications that has significantly reduced the pain and misery of various human conditions. Tis Issue’s Name Tat Drug Is: Chlordiazepoxide, aka: Librium;
chlordiazepoxide and clidinium (Librax) and chlordiazepoxide and amitriptyline (Limbitrol). ❚
Advancing The Gold Standard ®
www.datia.org
datia focus
57
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62